Citation: TIAN Hong, WU Jing-yan, SHANG You-jun, YING Shuang-hui, ZHENG Hai-xue, LIU Xiang-tao. Expression and Immunological Analysis of Capsid Protein Precursor of Swine Vesicular Disease Virus HK/70 .VIROLOGICA SINICA, 2010, 25(3) : 206-212.  http://dx.doi.org/10.1007/s12250-010-3100-x

Expression and Immunological Analysis of Capsid Protein Precursor of Swine Vesicular Disease Virus HK/70

  • Corresponding author: LIU Xiang-tao, hnxiangtao@hotmail.com
  • Received Date: 08 September 2009
    Accepted Date: 04 March 2010
    Available online: 01 June 2010
  • VP1, a capsid protein of swine vesicular disease virus, was cloned from the SVDV HK/70 strain and inserted into retroviral vector pBABE puro, and expressed in PK15 cells by an retroviral expression system. The ability of the VP1 protein to induce an immune response was then evaluated in guinea pigs. Western blot and ELISA results indicated that the VP1 protein can be recognized by SVDV positive serum, Furthermore, anti-SVDV specific antibodies and lymphocyte proliferation were elicited and increased by VP1 protein after vaccination. These results encourage further work towards the development of a vaccine against SVDV infection.

  • 加载中
    1. Borrego B, Carra E, Garcia-Ranea J A, et al. 2002. Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus. J Gen Virol, 83: 35-44.
        doi: 10.1099/0022-1317-83-1-35

    2. Brocchi E, Zhang G, Knowles N J, et al. 1997. Molecular epidemiology of recent outbreaks of swine vesicular disease: two genetically and antigenically distinct variants in Europe, 1987-1994. Epidemiol Infect, 118: 51-61.
        doi: 10.1017/S0950268896007170

    3. Dekker A. 2005. Herd sensitivity in relation to test sensitivity in swine vesicular disease serological tests. Rev sci tech Off int Epiz, 24 (3): 1077-1083.

    4. Graves J H. 1986. Swine vesicular disease. In: Diseases of Swine (Leman A D, Straw B, Glock R D, et al Eds.), 6th ed., Ames:Iowa State University Press, p384-352.

    5. Hu W S, Pathak V K. 2000. Design of retroviral vector and helper cells for gene therapy. Pharmacol Rev, 52: 493-511.

    6. Inoue T, Suzuli T, Sekiguchi K. 1989. The complete nucleotide sequence of swine vesicular disease virus. J Gen Virol, 70: 919-934.
        doi: 10.1099/0022-1317-70-4-919

    7. Jimenez-Clavero M A, Douglas A, Lavery T, et al. 2000. Immune recognition of swine vesicular disease virus structural proteins: novel antigenic regions that are not exposed in the capsid. Virol, 270: 76-83.
        doi: 10.1006/viro.2000.0256

    8. Kanno T, Inoue T, Wang Y, et al. 1995.Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants. J Gen Virol, 76: 3099-3106.
        doi: 10.1099/0022-1317-76-12-3099

    9. Kanno T, Mackay D, Inoue T, et al. 1999.Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus. J Virol, 73: 2710-2716.

    10. Kozak M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell, 44: 283-292.
        doi: 10.1016/0092-8674(86)90762-2

    11. Kwon Y J, Hung G, Anderson W F, et al. 2003. Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis. J Virol, 77: 5712-5720.
        doi: 10.1128/JVI.77.10.5712-5720.2003

    12. Nardelli L, Lodetti E, Gualandi G L, et al. 1968. A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature, 219: 1275-1276.
        doi: 10.1038/2191275a0

    13. Nijhar S K, Mackay D K., Brocchi E, et al. 1999. Identification of neutralizing epitopes on a European strain of swine vesicular disease virus. J Gen Virol, 80: 277-282.
        doi: 10.1099/0022-1317-80-2-277

    14. Rebel J M, Leendertse C H, Dekker A, et al. 2000. Construction of a full-length infectious cDNA clone of swine vesicular disease virus strain NET/1/92 and analysis of new antigenic variants derived from it. J Gen Virol, 81: 2763-2769.
        doi: 10.1099/0022-1317-81-11-2763

    15. Tsuda T, Tokui T, Onodera T. 1987. Induction of neutralizing antibodies by structural proteins VP1 and VP2 of swine vesicular disease virus. Jap J Vet Sci, 49: 129-132.
        doi: 10.1292/jvms1939.49.129

    16. Sun S Q, Liu X T, Guo H C, et al. 2007. Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus. J Gen Virol, 88 (Pt 3): 842-848.

    17. Vigna E, Naldini L. 2000. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gen Med, 2: 308-316.
        doi: 10.1002/(ISSN)1521-2254

    18. Zheng H X, Liu X T, Shang Y J, et al. 2006. Infective viruses produced from full-length complemen-tary DNA of swine vesicular disease viruses HK/70 strain. Chin Sci Bull, 51: 2072-2078.
        doi: 10.1007/s11434-006-2095-z

    19. Ye G S, Liu X T, Zhang Y M, et al. 2005. Determination and Analysis of Complete Nucleotide Sequence of Swine Vesicular Disease Virus. Chin J Virol, 21 (1): 69-71.

  • 加载中

Figures(2) / Tables(2)

Article Metrics

Article views(4109) PDF downloads(17) Cited by()

Related
Proportional views

    Expression and Immunological Analysis of Capsid Protein Precursor of Swine Vesicular Disease Virus HK/70

      Corresponding author: LIU Xiang-tao, hnxiangtao@hotmail.com
    • Key Laboratory of Animal Virology of Ministry of Agriculture, State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute of Chinese Academy of Agricultural Sciences, , Lanzhou 730046, .China

    Abstract: VP1, a capsid protein of swine vesicular disease virus, was cloned from the SVDV HK/70 strain and inserted into retroviral vector pBABE puro, and expressed in PK15 cells by an retroviral expression system. The ability of the VP1 protein to induce an immune response was then evaluated in guinea pigs. Western blot and ELISA results indicated that the VP1 protein can be recognized by SVDV positive serum, Furthermore, anti-SVDV specific antibodies and lymphocyte proliferation were elicited and increased by VP1 protein after vaccination. These results encourage further work towards the development of a vaccine against SVDV infection.